Filgrastim biosimilar (Shandong Quangang Pharmaceutical)

非格司亭生物类似药（山东泉港药业）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFilgrastim biosimilar (Shandong Quangang Pharmaceutical)

Drug Alias NameRecombinant Human Granulocyte Colony-stimulating Factor (Shandong Quangang Pharmaceutical)非格司亭生物仿制药（山东泉港药业）rhG-CSF (Shandong Quangang Pharmaceutical)重组人粒细胞刺激因子（山东泉港药业）Filgrastim follow-on biologic (Shandong Quangang Pharmaceutical) +[7]

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsNeutropenia

Approved Indications in ChinaNeutropenia

Original Approved Country/TerritoryMainland China

Original Approved Date2002/04/16

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesShandong Quangang Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesShandong Quangang Pharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsNeutropenia

Inactive IndicationsN/A

Other Information

ATC CodeL03AA02